Chief Scientific Officer. Cannabinologist
Ecovita Health Corp, Evitrade Health Systems
The Department of Pharmacology was established at UBC in 1951. A Therapeutics division was subsequently added to add focus to evidence based drug therapy. Recently, the department merged with Anesthesiology to foster interactions between basic and clinical scientists. Faculty members in the department of Anesthesiology, Pharmacology & Therapeutics are engaged in research in areas of neural, cardiovascular, respiratory and clinical pharmacology as well as drug development. Exceptional students with an undergraduate degree may be admitted directly into the Ph.D. program. Some students do a combined M.D./Ph.D. program for which a separate admission into the M.D. program, by the Faculty of Medicine, is required. Students pursuing a Ph.D. will have the opportunity to interact with basic as well as clinical scientists.
The shared research interests in anesthesiology, pharmacology, drug development and therapeutics allow students to gain broad-based exposure to fundamental as well as medically-related aspects of drug research. Research projects in the department are funded by operating grants from CIHR, NSERC, The Heart Foundation, etc. In addition, many of our students receive the highly competitive CIHR and NSRC studentship awards.
In order to apply to this program, the following components may be required.
All applicants must complete an online application form and pay the application fee to be considered for admission to UBC.
The Faculty of Graduate and Postdoctoral Studies establishes the minimum admission requirements common to all applicants, usually a minimum overall average in the B+ range (76% at UBC). The graduate program that you are applying to may have additional requirements. Please review the specific requirements for applicants with credentials from institutions in:
Each program may set higher academic minimum requirements. Meeting the minimum requirements does not guarantee admission as it is a competitve process.
Applicants from a university outside Canada in which English is not the primary language of instruction must provide results of an English language proficiency examination as part of their application. Tests must have been taken within the last 24 months at the time of submission of your application.
Minimum requirements for the two most common English language proficiency tests to apply to this program are listed below:
Some programs require additional test scores such as the Graduate Record Examination (GRE) or the Graduate Management Test (GMAT). The requirements for this program are:
A minimum of three references are required for application to graduate programs at UBC. References should be requested from individuals who are prepared to provide a report on your academic ability and qualifications.
Many programs require a statement of interest, sometimes called a "statement of intent", "description of research interests" or something similar.
Students in research-based programs usually require a faculty member to function as their supervisor. Please follow the instructions provided by each program whether applicants should contact faculty members.
This program has not specified whether applicants should reach out to faculty members. Please review the program website for additional details.
Permanent Residents of Canada must provide a clear photocopy of both sides of the Permanent Resident card.
Deadline to submit online application. No changes can be made to the application after submission.Transcript Deadline
Deadline to upload scans of official transcripts through the applicant portal in support of a submitted application. Information for accessing the applicant portal will be provided after submitting an online application for admission.Referee Deadline
Deadline for the referees identified in the application for admission to submit references. See Letters of Reference for more information.
|Fees||Canadian Citizen / Permanent Resident / Refugee / Diplomat||International|
|Installments per year||3||3|
|Tuition per installment||$1,698.56||$2,984.09|
|Tuition per year|
(plus annual increase, usually 2%-5%)
|Int. Tuition Award (ITA) per year (if eligible)||$3,200.00 (-)|
|Other Fees and Costs|
|Student Fees (yearly)||$944.51 (approx.)|
|Costs of living (yearly)||starting at $16,954.00 (check cost calculator)|
Applicants to UBC have access to a variety of funding options, including merit-based (i.e. based on your academic performance) and need-based (i.e. based on your financial situation) opportunities.
All full-time students who begin a UBC-Vancouver PhD program in September 2018 or later will be provided with a funding package of at least $18,000 for each of the first four years of their PhD. The funding package may consist of any combination of internal or external awards, teaching-related work, research assistantships, and graduate academic assistantships. Please note that many graduate programs provide funding packages that are substantially greater than $18,000 per year. Please check with your prospective graduate program for specific details of the funding provided to its PhD students.
All applicants are encouraged to review the awards listing to identify potential opportunities to fund their graduate education. The database lists merit-based scholarships and awards and allows for filtering by various criteria, such as domestic vs. international or degree level.
Student service appointments are intended to help qualified graduate students meet the cost of their studies at the University. Student appointments may involve part-time duties in teaching, research, or other academic activities.
Canadian and US applicants may qualify for governmental loans to finance their studies. Please review eligibility and types of loans.
All students may be able to access private sector or bank loans.
Many foreign governments provide support to their citizens in pursuing education abroad. International applicants should check the various governmental resources in their home country, such as the Department of Education, for available scholarships.
The possibility to pursue work to supplement income may depend on the demands the program has on students. It should be carefully weighed if work leads to prolonged program durations or whether work placements can be meaningfully embedded into a program.
Canadian residents with RRSP accounts may be able to use the Lifelong Learning Plan (LLP) which allows students to withdraw amounts from their registered retirement savings plan (RRSPs) to finance full-time training or education for themselves or their partner.
Please review Filing taxes in Canada on the student services website for more information.
Applicants have access to the cost calculator to develop a financial plan that takes into account various income sources and expenses.
23 students graduated between 2005 and 2013. Of these, career information was obtained for 19 alumni (based on research conducted between Feb-May 2016):
These statistics show data for the Doctor of Philosophy in Pharmacology (PhD). Data are separated for each degree program combination. You may view data for other degree options in the respective program profile.
This list shows faculty members with full supervisory privileges who are affiliated with this program. It is not a comprehensive list of all potential supervisors as faculty from other programs or faculty members without full supervisory privileges can request approvals to supervise graduate students in this program.
|2019||Dr. Carney studied the safety of medications commonly used to aid smoking cessation. He also developed a novel method of evaluating comparative effectiveness using health claims data. The results of his thesis will aid physicians, patients, and policy-makers to make informed choices regarding smoking cessation pharmacotherapy.|
|2019||Dr. Badran showed that intermittent hypoxia, a hallmark of obstructive sleep apnea, can cause uterine artery dysfunction during pregnancy and lead to cardiometabolic disease in the offspring using an animal model of sleep disordered breathing. His work provides insight in the pathophysiology of obstructive sleep apnea in pregnancy.|
|2018||Dr. Asiri developed the hypertonic saline analgesia assay, an efficient and inexpensive assay for testing analgesics in mice. He found that the new assay detected a broad range of analgesics using fewer animals compared to conventional assays and did not inflict undue suffering.|
|2018||Dr. Fung investigated the potential of using synthetic amino acids for the treatment of pain. His work identified the small molecule, ACBC, as being capable of alleviating responses in various experimental models of pain. These studies assist in the development of much needed new medicines for pain management.|
|2018||Isovaline is a rare amino acid brought to earth by meteorite in 1969. Dr. Asseri studied the effects of isovaline as an analgesic in animal pain models and brain tissue, discovering its potential to decrease neural excitability and reduce pain. These findings demonstrate that isovaline may serve as a prototype of painkillers with minimal side effects.|
|2017||Dr. Sellers studied the vascular biology of Marfan syndrome with a focus on understanding how current therapies work and finding new potential drug targets. Her work helps to better understand Marfan syndrome and provide the basis upon which to design new treatments for patients in the future.|
|2017||Dr. Osei assessed cell communication within the airways of asthmatic and COPD patients. His work showed the importance of Interleukin-1 alpha in the mediation of inflammation and fibrosis. This work increases our knowledge in chronic inflammation and remodelling that occurs in asthma and COPD, and provides avenues for new therapeutic research.|
|2017||Dr. Cui investigated the mechanisms underlying the progression of aortic aneurysm in Marfan syndrome - a genetic disorder of the connective tissue. He developed novel analyses of elastin that could lead to an early diagnostic method of the disease. His ultrasound studies strongly support potential use of doxycycline for prevention of Marfan-linked aneurysm.|
|2017||The human ether-à-go-go gene voltage-gated potassium channel, or hERG, plays a key role in the electrical activity of the heart. Dr. Macdonald investigated the structural bases for its abnormal gating and its propensity to off-target drug block. His work contributes to our understanding of voltage-gated potassium channel structure-function.|
|2017||Dr. Kim studied the mechanisms of an emerging class of therapeutics used for the treatment of epilepsy. His research revealed critical molecular interactions between a drug named retigabine and potassium channel proteins in the brain. These novel findings will contribute to the development of more effective therapies in the future.|
Pharmacology offers training in cardiovascular pharmacology, neuropharmacology, viral pharmacology, free radical biology, and drug development. Additional training programs exist in therapeutics, evidence-based medicine, and clinical investigation which reflecting the close association between the disciplines of anesthesiology, pharmacology, and therapeutics.